Vimarsana
Biggest News Aggregation in the World

Page 20 - Clinical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Sciences Today - Breaking & Trending Today

Africa-Europe partnership launches study to evaluate emergency response tools for severe malaria in highly isolated rural settings - Vimarsana News

Africa-Europe partnership launches study to evaluate emergency response tools for severe malaria in highly isolated rural settings

1

Imunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript - Vimarsana News

Imunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript

Imunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript November 17, 2023 Operator: Good morning. My name is Alan, and I will be your operator today. At this time I would like to welcome you to Imunon’s Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] I would like now to turn the call over to […]

Source: yahoo.com
Stress, hardship can affect couples sex drive – Gynaecologists - Vimarsana News

Stress, hardship can affect couples sex drive – Gynaecologists

Maternal health experts have said the unprecedented economic hardship could cause low sex drive (low libido) among couples.

Ul turns out 314 First Class graduates, celebrates 75th Founder Day - Vimarsana News

Ul turns out 314 First Class graduates, celebrates 75th Founder Day

The University of Ibadan, on Tuesday, held its 2023 convocation ceremony, where 6,865 graduated, and 314 bagging First Class degree. Speaking during the

Education key to curbing antimicrobial resistance in cats - Vimarsana News

Education key to curbing antimicrobial resistance in cats

Surveys tease apart how cat owners’ and veterinarians’ views may each be contributing to overuse of the only long-acting, injectable antimicrobial for use in cats, called cefovecin.